Kim L. McBride

5.3k total citations
108 papers, 2.7k citations indexed

About

Kim L. McBride is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Kim L. McBride has authored 108 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 33 papers in Genetics and 29 papers in Epidemiology. Recurrent topics in Kim L. McBride's work include Congenital heart defects research (30 papers), Congenital Heart Disease Studies (24 papers) and Lysosomal Storage Disorders Research (16 papers). Kim L. McBride is often cited by papers focused on Congenital heart defects research (30 papers), Congenital Heart Disease Studies (24 papers) and Lysosomal Storage Disorders Research (16 papers). Kim L. McBride collaborates with scholars based in United States, Canada and Australia. Kim L. McBride's co-authors include Matthew Pastore, Gail E. Herman, Sara Fitzgerald‐Butt, Liz Varga, Thomas W. Prior, Vidu Garg, Gloria Zender, John W. Belmont, Kevin M. Flanigan and Kandamurugu Manickam and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Kim L. McBride

105 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim L. McBride United States	30	1.3k	807	717	563	317	108	2.7k
Vandana Shashi United States	27	1.4k 1.1×	1.3k 1.6×	407 0.6×	129 0.2×	357 1.1×	98	2.9k
Stephanie M. Ware United States	35	3.1k 2.3×	1.1k 1.4×	1.5k 2.0×	1.4k 2.5×	597 1.9×	141	4.9k
Cynthia M. Powell United States	28	953 0.7×	1.2k 1.5×	182 0.3×	135 0.2×	141 0.4×	79	2.5k
Jan Wahlström Sweden	38	1.3k 1.0×	1.1k 1.4×	443 0.6×	149 0.3×	955 3.0×	136	4.3k
Antonio Novelli Italy	27	1.5k 1.2×	1.7k 2.1×	235 0.3×	150 0.3×	194 0.6×	305	3.4k
Thomas F. Wienker Germany	32	1.9k 1.4×	755 0.9×	238 0.3×	221 0.4×	193 0.6×	79	4.1k
Dorit Lev Israel	39	2.0k 1.5×	1.0k 1.3×	396 0.6×	133 0.2×	228 0.7×	188	4.9k
Erdogan Taskesen Netherlands	14	1.3k 1.0×	1.1k 1.3×	247 0.3×	112 0.2×	92 0.3×	20	2.8k
Robert J. Hopkin United States	40	1.5k 1.1×	1.1k 1.4×	1.5k 2.1×	215 0.4×	449 1.4×	189	5.8k
Nancy J. Mendelsohn United States	26	651 0.5×	859 1.1×	391 0.5×	166 0.3×	65 0.2×	51	2.1k

Countries citing papers authored by Kim L. McBride

Since Specialization

Citations

This map shows the geographic impact of Kim L. McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim L. McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim L. McBride more than expected).

Fields of papers citing papers by Kim L. McBride

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim L. McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim L. McBride. The network helps show where Kim L. McBride may publish in the future.

Co-authorship network of co-authors of Kim L. McBride

This figure shows the co-authorship network connecting the top 25 collaborators of Kim L. McBride. A scholar is included among the top collaborators of Kim L. McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim L. McBride. Kim L. McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Landis, Benjamin J., Stephanie M. Ware, Kim L. McBride, et al.. (2025). Identification of Long Noncoding RNA Candidate Disease Genes Associated With Clinically Reported Copy Number Variants in Congenital Heart Disease. Journal of the American Heart Association. 14(6). e039177–e039177.

Smith, Wendy E., Susan A. Berry, Christine Brown, et al.. (2024). Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 27(1). 101289–101289. 10 indexed citations

Yatsenko, Svetlana A., Cecilia Lo, Xinxiu Xu, et al.. (2024). Case Report: An association of left ventricular outflow tract obstruction with 5p deletions. Frontiers in Genetics. 15. 1451746–1451746. 1 indexed citations

Almeida, Camila de, Nianyuan Huang, W. David Arnold, et al.. (2023). Promising AAV.U7snRNAs vectors targeting DMPK improve DM1 hallmarks in patient-derived cell lines. Frontiers in Cell and Developmental Biology. 11. 3 indexed citations

Li, Ming, William L. Border, Sara Fitzgerald‐Butt, et al.. (2023). A multicenter cross-sectional study in infants with congenital heart defects demonstrates high diagnostic yield of genetic testing but variable evaluation practices. SHILAP Revista de lepidopterología. 1(1). 100814–100814. 9 indexed citations

Ramesh, Naveen, Min Hu, Sayaka Hashimoto, et al.. (2022). A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties. Journal of Molecular Diagnostics. 24(9). 1031–1040. 3 indexed citations

Gordon, David, David Cunningham, Gloria Zender, et al.. (2022). Exome sequencing in multiplex families with left-sided cardiac defects has high yield for disease gene discovery. PLoS Genetics. 18(6). e1010236–e1010236. 15 indexed citations

Saville, Jennifer T., et al.. (2019). Evaluation of biomarkers for Sanfilippo syndrome. Molecular Genetics and Metabolism. 128(1-2). 68–74. 16 indexed citations

McBride, Kim L., et al.. (2018). Natural history of echocardiographic abnormalities in mucopolysaccharidosis III. Molecular Genetics and Metabolism. 124(2). 131–134. 12 indexed citations

10.

Fu, Haiyan, et al.. (2017). Differential prevalence of antibodies against adeno-associated virus in healthy children and patients with mucopolysaccharidosis III: perspective for AAV-mediated gene therapy. 1 indexed citations

11.

Fu, Haiyan, et al.. (2017). Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy. PubMed. 28(4). 187–196. 40 indexed citations

12.

Fu, Haiyan, Douglas M. McCarty, Kelly McNally, et al.. (2016). A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design. Molecular Genetics and Metabolism. 119(3). 239–248. 40 indexed citations

13.

LaHaye, Stephanie, Jessica Bowman, Sara Fitzgerald‐Butt, et al.. (2015). Abstract 12295: Utilization of Whole-Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease. Circulation. 132(suppl_3). 1 indexed citations

14.

Hinton, Robert B., Kim L. McBride, Steven B. Bleyl, et al.. (2015). Rationale for the Cytogenomics of Cardiovascular Malformations Consortium: A Phenotype Intensive Registry Based Approach. PMC. 2 indexed citations

15.

Meadows, Aaron S., F. Jason Duncan, Marybeth Camboni, et al.. (2015). A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB. PubMed. 26(4). 228–242. 20 indexed citations

16.

Bonachea, Elizabeth, Gloria Zender, Peter White, et al.. (2014). Use of a targeted, combinatorial next-generation sequencing approach for the study of bicuspid aortic valve. BMC Medical Genomics. 7(1). 56–56. 43 indexed citations

17.

Murrey, Darren, Bartholomew J. Naughton, F. Jason Duncan, et al.. (2014). Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating MPS IIIB: Toxicology, Bio-distribution and Immunological Assessments in Primates. 776275620–776275620. 6 indexed citations

18.

Murrey, Darren, Bartholomew J. Naughton, F. Jason Duncan, et al.. (2014). Feasibility and Safety of Systemic rAAV9-h NAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates. PubMed. 25(2). 72–84. 83 indexed citations

19.

McBride, Kim L. & Vidu Garg. (2010). Impact of Mendelian inheritance in cardiovascular disease. Annals of the New York Academy of Sciences. 1214(1). 122–137. 12 indexed citations

20.

Fitzgerald‐Butt, Sara, Lindsey Byrne, Cynthia A. Gerhardt, et al.. (2009). Parental Knowledge and Attitudes Toward Hypertrophic Cardiomyopathy Genetic Testing. Pediatric Cardiology. 31(2). 195–202. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact